Trea
tment optimisation in drug development
: study : Panel for the Future of Science and Technology
Parlamento Europeo
Dirección General de Servicios de Estudios Parlamentarios
text
technical report
be
Brussels
European Union
March 2020
2020
monographic
eng
pdf
V, 70 p. ; 1 documento PDF
The development of novel health technologies is a complex and costly process that follows an extensive set of regulatory guidelines and legal provisions intended to ensure that the treatments reach the patients that need them in a highly controlled and standardised manner
specialized
/ EPRS - European Parliamentary Research Service
Bibliografía: p. 66-70
Reproduction and translation for non-commercial purposes are authorised, provided the source is acknowledged and the European Parliament is given prior notice and sent a copy.
Sanidad digital
treatment optimisation
clinical drug
treatment
patient
public health
industry
pdf
978-92-846-6037-7
https://www.europarl.europa.eu/RegData/etudes/STUD/2020/641511/EPRS_STU(2020)641511_EN.pdf
https://www.europarl.europa.eu/RegData/etudes/STUD/2020/641511/EPRS_STU(2020)641511_EN.pdf
Reproduction and translation for non-commercial purposes are authorised, provided the source is acknowledged and the European Parliament is given prior notice and sent a copy.
ES-MaONT
200318
20211006062658.0
00005744